Rodríguez-Acar M, Ramos-Garibay A, Mejía-Granilla R

Language: Spanish
References: 11
Page: 26-31
PDF size: 315.07 Kb.

Text Extraction

No abstract.

REFERENCES

1. Telich TJE, Monter PA, Baldín AV, Apellaniz CA. Diagnóstico y tratamiento de los tumores malignos de piel. Acta Med. 2017; 15: 154-160.

2. Torres LV, Camacho MC, Sober-Ignacio SA. Dermatología práctica ibero-latinoamericana. 2ª ed., Tomo II, pp. 133.1-133.9.

3. Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007; 29: 621-631.

4. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005; 53: 253-260.

5. DeSimone Ja, Pritesh SK, Schmults CD. Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma. Up To Date. 2014. www.uptodate.com.

6. Stasko T, Brown MD, Carucci JA, Euvrard S, Johnson TM, Sengelmann RD et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg. 2004; 30: 642-650.

7. Lin JM, Yan Pan, Jalilian C, W. Kelly JW. Dermoscopic characteristics of nodular squamous cell carcinoma and keratoacanthoma. Dermatol Pract Concept. 2014; 4: 9-15.

8. Renzi C, Mastroeni S, Mannooranparamil T, Passarelli F, Pasquini P. Timely diagnosis of cutaneous squamous cell carcinoma: the GP’s role. Family Practice. 2011; 28: 277-279.

9. Brougham DN, Tan ST. Incidence and risk factors of metastasis for cutaneous squamous cell carcinoma-implications on the T-classification system. J Surg Oncol. 2014; 110: 876-882.

10. Nuño-González A, Vicente-Martina F, Pinedo-Moraleda F, López-Estebaranz J. Carcinoma epidermoide cutáneo de alto riesgo. Actas Dermo-Sifiliog. 2012; 103: 567-578.

11. Parikh SA, Patel VA, Ratner D. Advances in the management of cutaneous squamous cell carcinoma. F1000Prime Rep. 2014; 6: 70.